NN
Nagaraju Nallagatla
About Nagaraju Nallagatla
Data last updated:
Nagaraju Nallagatla is a Director at Neocell Science Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Neocell Science Pharmaceuticals Private Limited reported revenue of ₹3.61 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neocell Science Pharmaceuticals Private Limited U51909TG2019PTC135631 | Director | 23 Sep 2019 | 2019 | ₹3.61 Cr (FY 2024) | Active |
Board colleagues of Nagaraju Nallagatla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagiyassi Harish Kumar | 08569900 | Neocell Science Pharmaceuticals Private Limited | Director |
| Jagiyassi Nirmala | 08569898 | Neocell Science Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nagaraju Nallagatla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nagaraju Nallagatla
Nagaraju Nallagatla currently holds 1 directorship: Neocell Science Pharmaceuticals Private Limited (Director, since 23 Sep 2019, revenue ₹3.61 Cr (FY 2024)).
Nagaraju Nallagatla was first appointed on 23 Sep 2019 as Director at Neocell Science Pharmaceuticals Private Limited.
The current boards of Nagaraju Nallagatla's companies include Jagiyassi Harish Kumar (Neocell Science Pharmaceuticals Private Limited), Jagiyassi Nirmala (Neocell Science Pharmaceuticals Private Limited).